Stock Hot Tips

StockHotTips.com Hot Stock News & Alerts!

******************************************************************

Potential to Distribute Over 1,000 Karaoke Vending Units in First 12 Months

NEW YORK, (CRWENEWSWIRE) MARCH 12, 2010 — Mobile Star Corp. (OTCBB:MBST.ob - News), a developer of coin-operated karaoke vending machines, announced today that the company has reached a preliminary distribution agreement with Apple Industries, one of North America’s premier manufacturers and distributors of coin-operated electronic entertainment.

Apple Industries plans to distribute the Mobile Star’s next-generation entertainment vending booth, utilizing its well-established marketing channels. Apple Industries currently operates a vast distribution network, placing products in shopping centers, amusement parks, theaters, casinos, restaurants, pubs, and various other tourist attractions.

The preliminary agreement follows the successful pilot of the Mobile Star during the recently concluded Holiday Season. The pilot, which was closely monitored by Apple Industries’ professional team, confirmed the quality of the vending machine and demonstrated greater return on investment potential than initially anticipated

Each vending machine is expected to generate over $30,000 in gross annual revenues.

“We plan to begin marketing the machine in the second half of 2010, and we reasonably expect to distribute over 1,000 units in the first 12 months,” said Allen Weisberg, President of Apple Industries. “Today there are over 40,000 bars nationwide with jukeboxes. We anticipate placing the Mobile Star in many of these locations in the coming years, in addition to other locations such as nationwide theater chains, etc.”

“The Mobile Star fits right into our lineup of machines that are innovative and fun, and bring owners a satisfying return on investment. With the growing national interest in karaoke, stemming from song contests like American Idol, we are confident that the Mobile Star will quickly become a market winner,” Weisberg added.

“We are excited to join forces with Apple Industries, a long-standing market leader with over 45-years experience distributing entertainment vending machines,” said Danny Elbaz, CEO of Mobile Star Corp. “The combination of Apple’s incredible marketing channels, in tandem with the Mobile Star’s patented technology will produce a hit that will take us to the top of the charts.”

About Apple Industries

Apple Industries is a premiere manufacturer and distributor of coin operated electronic entertainment, representing some of the finest vending manufactures in the World. Apple Industries is a wholly-owned private US company with 45 years of history, and distribution channels throughout the U.S. and Canada. Apple’s products can be found in shopping centers, amusement parks, theaters, casinos, tourist attractions, Restaurants and Pubs and more.

About Mobile Star

Mobile Star has developed a free-standing entertainment vending machine that enables an individual to digitally record his or her voice singing to hundreds of songs. The patented karaoke technology utilizes a proprietary digital-media software platform, and professional-grade hardware to publish a high quality CD of the performance.

For more information on Mobile Star, please visit http://themobilestar.com.

Forward-Looking Statements

This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of Mobile Star Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated. Mobile Star Corp. public filings may be viewed at http://www.sec.gov.

Contact:

CEO, Danny Elbaz
danny@themobilestar.com
+972-54-465-5341

******************************************************************

Be sure to Check Out StockHotTips.ning.com

***********Advertisement***********

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer

: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.Stock Hot Tips publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold StockHotTips.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has received thirty thousand dollars cash compensation from a third party (AIZER FOUNDATION INC) for 30 days of media advertisement services for Mobile Star Corp. (MBST.OB).

** The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings, Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.

mbst_stockhottips1

StockHotTips.com Hot Stock News & Alerts!

Monday December 07, 2009

******************************************************************

Brooklyn, NY - (WORLD STOCK WIRE) via (CRWE NEWSWIRE)- December 7, 2009 — PowerSafe Technology Corporation (OTC: PSFT) subsidiary Amplification Technologies Inc. (www.ampti.net) (ATI), and BFi OPTiLAS (www.bfioptilas.com) today announced a mutually exclusive distribution agreement. BFi OPTiLAS will market and distribute the full line of ATI’s innovative Discrete Amplification (DA) devices for low-level light detection throughout Europe.

“BFi OPTiLAS is a perfect fit for ATI” said Avery Kornbluth, COO of ATI. “We consider BFi OPTiLAS to be a valued extension of our sales force, and look forward to a long and successful relationship.”

“We are excited to add ATI’s patented Discrete Amplification technology to our product set” said Jean-Claude Sanudo, Business Development Director of BFi OPTiLAS. “Our customers will now be able to experience these next generation photodetection devices.”

About PowerSafe Technology Corp. (PSFT)

Based in New York, PowerSafe Technology Inc. (www.psftinc.com) , thru its wholly owned subsidiary ATI, (www.ampti.net) seeks to transform the field of low-level signal detection. The company’s patented platform semiconductor technology has the potential to offer unparalleled and far-reaching benefits to industries such as medical diagnostics, drug development, scientific instrumentation and homeland security. The technology has been successfully used to develop extremely sensitive detectors of low levels of light and the company believes its detectors will be used in many existing applications as well as open up new markets. ATI’s technology is patented to encompass detection of signals other than light, and could in principle be used to create highly sensitive biological, radiological, electrical, and chemical sensors.

About BFi OPTiLAS

BFi OPTiLAS is a pan-European technical distributor of specialist products and services, including design-engineering support, to the electronics and Photonics markets. BFi OPTiLAS focuses on niche technology products such as lasers, electro-optics, imaging, fiber optics, magnetic, sensors, connectors, RF & microwave and other specialty components, systems, assemblies and metals. Some 300 sales engineers and other staff are employed at 12 offices throughout Europe.

Forward-Looking Statements
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of PowerSafe and Amplification. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties inherit herein and set forth in PowerSafe’s SEC filings and such other matters as are contained therein. These risks and uncertainties could cause actual results to differ materially from those indicated in the forward-looking statements.

Contact
Avery Kornbluth, COO
Amplification Technologies Inc.
(718) 951-8021
averyk@amplificationtechnologies.com

PR Contact
Jack Mayer, Pres.
PowerSafe Technology Corp.
(718) 951-8021
mayer@amplificationtechnologies.com

-
PowerSafe Technology Corporation
1400 Coney Island Avenue
Brooklyn, NY 11230
USA

Phone: (718) 951-8021

Note: The following news is from PowerSafe Technology Corporation, and World Stock Wire, Inc. is not liable for the contents of this news.

******************************************************************

***********Advertisement***********

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer

: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.Stock Hot Tips publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold StockHotTips.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more) Rule 17B requires disclosure of payment for investor relations.Crown Equity Holdings, Inc. (CRWE.OB) has received five thousand dollars from a third party for 30 days of advertisement services for PowerSafe Technology Corp. (PSFT.PK).

StockHotTips.com Hot Stock News & Alerts!

Friday December 04, 2009

******************************************************************

ASHBURN, VA- (CRWENEWSWIRE) Dec 2,2009, -Red Branch Technologies, Inc. (Pinksheets:RBTI - News) announced today that its Board of Directors met today in a special session to authorize the opening of an immediate investigation by its General Counsel, Robert J. Flynn, Jr. Esq., into irregular stock trading patterns and possible “short-style selling” in the company shares.

RBTI’s CEO, Jeff Sirianni, says, “We are determined to make a diligent and thorough investigation and to assure market confidence in the business direction that we have undertaken at Red Branch. Keep in mind; nothing has fundamentally changed with our company. We will continue to stay focused on implementing our business model and to aggressively pursue new business.”

About Red Branch Technologies, Inc.:

Red Branch Technologies provides sustainable-energy-powered solutions meeting commercial, industrial, municipal and federal requirements for site security, materials control, emergency communications, water purification and similar on-site applications. The company’s ability to simultaneously manage multiple renewable energy sources allows Red Branch Technologies powered solutions to stay up and running longer than the competition. Mobility is another differentiating aspect of Red Branch Technologies’ solutions.

The company also offers a unique set of security products for military and law enforcement applications where cost/performance represents a critical selection factor. The application areas include Explosive Ordinance Disposal (EOD) robots, vehicular inspection and Unmanned Aerial Vehicles (UAVs).

More detailed information can be found at www.RedBranchTech.com.

Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words “estimate,” “anticipate,” “expect,” “believe,” and similar expressions are intended to be forward-looking statements.
Contact:

Contact:
Investor Relations
David Donlin
Cervelle Group
Phone: 407-614-5959 ext. 223

CRWENewswire tracks and announces stocks daily and is pleased to offer its Stock Alerts. Investors can receive FREE Stock Alerts by visiting http://www.crwenewswire.com/signup

About CRWENewswire.com

CRWENewswire.com is an independent electronic informative online financial news publication company dedicated in providing company associates, business and financial professionals with economic and investment information, as well as stock highlights. CRWENewswire.com is a division of Crown Equity Holdings, Inc.

CRWENewswire.com is not a registered investment advisor or broker-dealer. CRWENewswire.com and Crown Equity Holdings, Inc., (CRWE) affiliates, officers, directors, contractors and employees, including may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Release of Liability: Through use of this website viewing or using, you agree to hold CRWENewswire.com, and/or Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur.

******************************************************************

***********Advertisement***********

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer

: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.Stock Hot Tips publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold StockHotTips.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more) Rule 17B requires disclosure of payment for investor relations.

StockHotTips.com Hot Stock News & Alerts!

Friday December 04, 2009

******************************************************************

HZHI, Horizon Health International Corp., HZHI.PK HZHI

through its US and Canadian Subsidiaries is servicing all of North America through its E-Commerce System, providing services as a ‘Home, Office and Workplace Medical Equipment Specialist’ offering a complete end-to-end shopping experience for aids for daily living, disability products, ergonomic solutions and leading-edge assistive technology through online retail stores across North America. HZHI entered into an agreement with Exmovere Holdings for the exclusive rights to market the “Chariot” and the “Telepath” in Canada on Nov. 20, 2009. “The Chariot” is a mobility device that can be implemented by millions of people suffering from mobility problems. It is the only, truly hands free, self-balancing vehicle. It also serves as a unique platform for integrating vital sign, emotion monitoring and environmental sensors for hospitals, military and hazardous materials workers. It is a new wearable device that will help people with physical challenges to get around. “The Telepath” is the world’s first and only Zigbee biosensor wristwatch that uses infrared sensors to detect heart rate without a chest strap, 3-d accelerometers to model human movement, and a variety of metallic sensors to detect skin temperature and skin conductance. The Telepath transmits these data via computer or cell phone to online data centers, care givers and/or emergency services. The market for mobility devices is extremely large; in 2008, Canada exported US$4.2 million worth of mechanically propelled wheelchairs and mobility scooters. That number represents a 114.1% gain over the $1.9 billion in powered mobility aids sold 4 years earlier in 2004. Canadians imported $24.1 million worth of power wheelchairs and mobility scooters last year. Canada imported almost $20 million more in battery-assisted mobility imports than it shipped as exported goods. HZHI and Exmovere Holdings Inc. will be conducting demonstrations of the “Chariot” and the “Telepath” (a BioSensor Wristwatch) to the Investment Community in Canada, commencing in January 2010. The door is Opening to Enter the Multi Million Dollar Mobility Aid and BioSensor Products Market for HZHI Contacts: Horizon Health International Corp. Delbert G. Blewett President 604-998-3385 horizonhealth@shaw.ca www.Horizonhealthandsafety.com

******************************************************************

***********Advertisement***********

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer

: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.Stock Hot Tips publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold StockHotTips.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more) Rule 17B requires disclosure of payment for investor relations.Crown Equity Holdings Inc has been compensated in a joint venture with Xplosivestocks.com $25,000 dollars from a third party for advertisment services for HZHI.PK, Horizon Health International Corp.

StockHotTips.com Hot Stock News & Alerts!

Friday December 04, 2009

******************************************************************

PALO ALTO, Calif.–(CRWE NEWSWIRE)–StemCells, Inc. (NASDAQ: STEM - News) announced today that it welcomes the approval yesterday by the National Institutes of Health (NIH) of the first 13 human embryonic stem cell (hESC) lines for use in NIH-funded research under the NIH Guidelines for Human Stem Cell Research adopted in July 2009. The guidelines implement President Obama’s executive order of March 9, 2009 permitting the federal government, through the NIH, to support and conduct responsible, scientifically worthy human stem cell research, including human embryonic stem cell research. Stem cell research holds the potential to advance the understanding of many diseases at a fundamental, cellular level, and may open new avenues for treatments or cures. The Company considers this action by the federal government as a critical first step for the advancement of the stem cell field and for the future practice of medicine.

StemCells is focused on the development and commercialization of cell-based technologies, including technologies relating to embryonic stem cells, induced pluripotent stem (iPS) cells, and tissue-derived (adult) stem cells. In its cellular medicine product development programs, the Company is currently focused on developing tissue-derived (adult) stem cells as cell-based therapeutics. The Company’s lead product candidate, HuCNS-SC® cells (purified human neural stem cells), is in clinical development for the treatment of two fatal neurodegenerative disorders that primarily affect young children.

Through the acquisition of the operating business of Stem Cell Sciences Plc in April of this year, StemCells added a number of proprietary assets relating to a range of stem and progenitor cell technologies, including four embryonic stem cell lines (MEL 1 to 4), which were developed by Company scientists, cell culture media for iPS derivation, and expertise and infrastructure for providing cell-based assays for drug discovery using a variety of cell types. While not currently developing embryonic stem cells for therapeutic use, the Company is presently evaluating the many cell lines acquired from Stem Cell Sciences, including embryonic stem cells, as potential therapeutics for diseases and disorders of the central nervous system.

About StemCells, Inc.

StemCells, Inc. is focused on the development and commercialization of cell-based technologies. In its cellular medicine programs, StemCells is targeting diseases of the central nervous system and liver. StemCells’ lead product candidate, HuCNS-SC cells (purified human neural stem cells), is in clinical development for the treatment of two fatal neurodegenerative disorders that primarily affect young children. StemCells also markets specialty cell culture media products under the brand SC Proven®, and is developing its cell-based technologies for use in drug screening and drug development. The Company has exclusive rights to approximately 55 issued or allowed U.S. patents and approximately 200 granted or allowed non-U.S. patents. Further information about StemCells is available at www.stemcellsinc.com.

Apart from statements of historical fact, the text of this press release constitutes forward-looking statements within the meaning of the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended, and is subject to the safe harbors created therein. These statements include, but are not limited to, statements regarding the potential for the Company’s therapies to treat PMD, NCL and other serious neurodegenerative diseases, the potential for its cell-based therapeutics to treat other diseases or disorders, and the future business operations of the Company, including its ability to conduct clinical trials as well as its other research and product development efforts. These forward-looking statements speak only as of the date of this news release. The Company does not undertake to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof. Such statements reflect management’s current views and are based on certain assumptions that may or may not ultimately prove valid. The Company’s actual results may vary materially from those contemplated in such forward-looking statements due to risks and uncertainties to which the Company is subject, including uncertainty as to whether the FDA or other applicable regulatory agencies will permit the Company to continue clinical testing of proposed therapies given the novel and unproven nature of the Company’s technologies; uncertainties regarding the Company’s ability to obtain the increased capital resources needed to continue its current and planned research and development operations, including such operations of the Company for non-therapeutic applications, and to conduct the research, preclinical development and clinical trials necessary for regulatory approvals; uncertainty as to whether HuCNS-SC and any products that may be generated in the future in the Company’s cell-based programs will prove safe and clinically effective and not cause tumors or other adverse side effects; uncertainties regarding the Company’s ability to commercialize a therapeutic product and its ability to successfully compete with other products on the market; uncertainties regarding the Company’s manufacturing capabilities given its increasing preclinical and clinical commitments; and the increased risks associated with commercializing future cell-based therapeutics, including the potential for product liability claims; and other factors that are described under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2008, and in its subsequent reports on Form 10-Q and Form 8-K.

Contact:

StemCells, Inc.
Megan Meloni, 650-475-3100, ext. 105
(Investor Inquiries)

******************************************************************

***********Advertisement***********

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer

: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.Stock Hot Tips publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold StockHotTips.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more) Rule 17B requires disclosure of payment for investor relations.